Samarth Kulkarni

Samarth Kulkarni currently works at CRISPR Therapeutics AG, as Chairman & Chief Executive Officer from 2023, CRISPR Therapeutics, Inc., as Chairman & Chief Executive Officer, Oruka Therapeutics, Inc., as Chairman from 2024, and Black Diamond Therapeutics, Inc., as Lead Independent Director from 2023.
Dr. Kulkarni also formerly worked at Casebia Therapeutics LLP, as Chairman, Repare Therapeutics, Inc., as Independent Director from 2019 to 2026, Casebia Therapeutics LLC, as Director, Biotechnology Innovation Organization, as Director-Emerging Companies Section, Centessa Pharmaceuticals Plc, as Independent Non-Executive Director from 2021 to 2026, and McKinsey & Co., Inc., as Partner from 2006 to 2015.
Dr. Kulkarni received his doctorate degree from the University of Washington and undergraduate degree from Indian Institute of Technology New Delhi.